OtherPublishAheadOfPrint
Downregulation of 18F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus
Lucia Nogová, Ronald Boellaard, Carsten Kobe, Nikie Hoetjes, Thomas Zander, Stefan Hubert Gross, Sasa Dimitrijevic, Theodore Pellas, Wolfgang Eschner, Katja Schmidt, Christopher Bangard, Wendy Hayes, Roman K. Thomas, Markus Dietlein, Giuseppe Giaccone, Otto S. Hoekstra, Adriaan A. Lammertsma and Jürgen Wolf
Journal of Nuclear Medicine October 2009, DOI: https://doi.org/10.2967/jnumed.109.065367
Lucia Nogová
Ronald Boellaard
Carsten Kobe
Nikie Hoetjes
Thomas Zander
Stefan Hubert Gross
Sasa Dimitrijevic
Theodore Pellas
Wolfgang Eschner
Katja Schmidt
Christopher Bangard
Wendy Hayes
Roman K. Thomas
Markus Dietlein
Giuseppe Giaccone
Otto S. Hoekstra
Adriaan A. Lammertsma
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Downregulation of 18F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus
Lucia Nogová, Ronald Boellaard, Carsten Kobe, Nikie Hoetjes, Thomas Zander, Stefan Hubert Gross, Sasa Dimitrijevic, Theodore Pellas, Wolfgang Eschner, Katja Schmidt, Christopher Bangard, Wendy Hayes, Roman K. Thomas, Markus Dietlein, Giuseppe Giaccone, Otto S. Hoekstra, Adriaan A. Lammertsma, Jürgen Wolf
Journal of Nuclear Medicine Oct 2009, DOI: 10.2967/jnumed.109.065367
Downregulation of 18F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus
Lucia Nogová, Ronald Boellaard, Carsten Kobe, Nikie Hoetjes, Thomas Zander, Stefan Hubert Gross, Sasa Dimitrijevic, Theodore Pellas, Wolfgang Eschner, Katja Schmidt, Christopher Bangard, Wendy Hayes, Roman K. Thomas, Markus Dietlein, Giuseppe Giaccone, Otto S. Hoekstra, Adriaan A. Lammertsma, Jürgen Wolf
Journal of Nuclear Medicine Oct 2009, DOI: 10.2967/jnumed.109.065367
Jump to section
Related Articles
Cited By...
- A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer
- Biological Correlation of 18F-FDG Uptake on PET in Pulmonary Neuroendocrine Tumors
- Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment
- Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues